SCHEMBL13049463

SCHEMBL13049463

C/C(=C\C1=C(Cl)C(=O)c2ccccc2C1=O)C(=O)NCCCCCCNC(=O)CCCCC1C2NC(=O)NC2CS1(=O)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APEX1 P27695 4/20 0.49
▸ TDP1 Q9NUW8 2/20 0.38
▸ ITGB1 P05556 1/20 0.36
▸ ITGA4 P13612 1/20 0.36
▸ CNR1 P21554 3/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ NR2E3 Q9Y5X4 1/20 0.35
▸ NCOR2 Q9Y618 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ FLI1 Q01543 1/20 0.34
▸ EWSR1 Q01844 1/20 0.34
▸ CAPN1 P07384 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13049585 0.81 KEAP1 (0.35) TDP1ITGB1ITGA4CNR1ALDH1A1
SCHEMBL13049468 0.81 KEAP1 (0.35) TDP1ITGB1ITGA4CNR1ALDH1A1
SCHEMBL13079435 0.81 KEAP1 (0.35) TDP1ITGB1ITGA4CNR1ALDH1A1
SCHEMBL13079426 0.81 TDP1 (0.55) APEX1TDP1ALDH1A1HPGDPPARG
SCHEMBL13049470 0.81 TDP1 (0.55) APEX1TDP1ALDH1A1HPGDPPARG
SCHEMBL19751702 0.75 TDP1 (0.48) TDP1ITGB1ITGA4ALDH1A1HPGD
SCHEMBL18501099 0.75 TDP1 (0.48) TDP1ITGB1ITGA4CNR1ALDH1A1
SCHEMBL4965653 0.75 TDP1 (0.48) TDP1ITGB1ITGA4ALDH1A1HPGD
SCHEMBL4962526 0.74 TDP1 (0.50) TDP1ITGB1ITGA4CNR1ALDH1A1
SCHEMBL13080217 0.74 TDP1 (0.48) TDP1ITGB1ITGA4CNR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 — — US disclosed
US-9089605-B2 Quinone derivatives, pharmaceutical compositions, and uses thereof INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-28 — — US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 — — US disclosed
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 APEX1 1/4885TDP1 118/4885ITGB1 4691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback